@article{43b97d93edb142d0b74938653f6581cc,
title = "Close antiplatelet therapy monitoring and adjustment based upon thrombelastography may reduce late-onset bleeding in HeartMate II ecipients",
author = "Ashkan Karimi and Beaver, \{Thomas M.\} and Hess, \{Philip J.\} and Martin, \{Tomas D.\} and Staples, \{Edward D.\} and Schofield, \{Richard S.\} and Hill, \{James A.\} and Aranda, \{Juan M.\} and Klodell, \{Charles T.\}",
note = "HeartMate II (Thoratec Corporation, Pleasanton, CA, USA) is the most commonly implanted left ventricular assist device (LVAD) not only in the USA but worldwide [ 1]. Bleeding is the most common complication of HeartMate II [ 2-4].",
year = "2014",
month = apr,
day = "1",
doi = "10.1093/ICVTS/IVT546",
language = "American English",
volume = "18",
journal = "Interactive Cardiovascular and Thoracic Surgery",
issn = "1569-9285",
publisher = "Oxford University Press",
number = "4",
}